XJPX
2483
Market cap48mUSD
Jul 09, Last price
2,356.00JPY
1D
0.26%
1Q
32.36%
Jan 2017
35.21%
IPO
-53.35%
Name
Honyaku Center Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Honyaku Center Inc., established in 1986 and based in Osaka, Japan, delivers a comprehensive suite of translation and linguistic services to clients globally. The company specializes in technical documents across diverse fields, including patent applications and related legal proceedings, as well as medical texts covering basic research, clinical development, regulatory submissions, and post-market surveillance. Their expertise also extends to financial and legal materials, such as corporate disclosures, transactional documents, and general finance, in addition to IT documentation and technical manuals. For industrial clients, they translate materials ranging from R&D, planning, and design specifications to production, quality assurance, implementation, maintenance records, and sales/marketing collateral, along with content for non-manufacturing sectors. Beyond core translation, Honyaku Center Inc. provides medical writing, grammar checks, transcription, staffing solutions, multilingual contact center operations, proofreading, back translation, and support for foreign patent applications. They also prepare drawings and offer digital content localization for computer games, e-learning platforms, and websites. Furthermore, the company assists individuals with visa-related documentation for marriage, work, residency, or study abroad, and offers desktop publishing (DTP), printing, general document services, e-book translation, and localization for marketing materials like pamphlets, catalogs, press releases, newsletters, and presentations. Honyaku Center Inc. serves a broad spectrum of industries, including automotive, mechanical, electronics, pharmaceuticals, legal, finance, research and development, and education.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||